Find information on thousands of medical conditions and prescription drugs.

Alkaptonuria

Alkaptonuria also known as alcaptonuria or ochronosis is a rare inherited genetic disorder of tyrosine metabolism. more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Causes

This is an autosomal recessive trait that is caused by a defect in the enzyme homogentisic acid oxidase (EC 1.13.11.5). The enzyme normally breaks down a toxic tyrosine byproduct, homogentisic acid (also called alkapton), which is harmful to bones and cartilage and is excreted in urine.

Symptoms

A distinctive characteristic of alkaptonuria is that urine exposed to air turns dark (or black) after several hours because of the homogentisic acid. In adulthood, persons suffering from alkaptonuria develop progressive arthritis (especially of the spine), due to its degenerative effects on bones and cartilage.

Diagnosis

Presumptive diagnosis can be made by adding sodium or potassium hydroxide to urine and observing the formation of a dark brown to black pigment on the surface layer of urine within 30 minutes to 1 hour. Diagnosis can be confirmed by demonstrating the presence of homogentisic acid in the urine. This may be done by paper chromatography and thin-layer chromatography (Seegmiller, 1998).

Treatment

Prevention is not possible and the treatment is aimed at ameliorating symptoms.

Read more at Wikipedia.org


[List your site here Free!]


Alkaptonuria diagnosed by flexible bronchoscopy
From CHEST, 11/1/05 by Joseph G. Parambil

A 68-year-old white man was evaluated for failure to wean from mechanical ventilation after cardiac surgery. Bronchoscopy performed prior to percutaneous dilatational tracheotomy revealed circumferential strikingly dark-colored airways, most prominent in the trachea and mainstem bronchi, extending distally into all airways with overlying desiccated black secretions. Histologic examination of bronchial mucosal biopsy samples and the desiccated secretions showed acute bronchitis and necrotic debris, respectively. This finding and the patient's history led to testing for plasma homogentisic acid, which was found to be elevated at 12.6 [micro]/mL, establishing the first diagnosis of alkaptonuria made using flexible bronchoscopy.

Key words: alkaptonuria; bronchoscopy; homogentisic acid

Abbreviations: HGA = homogentisic acid; HGO = homogentisate 1, 2-dioxygenase

**********

Alkaptonuria (ochronosis) is an inherited disorder of amino acid metabolism (1) affecting the degradation of phenylalanine and tyrosine. (2) These amino acids are degraded along the tyrosine degradation pathway to acetoacetic acid and fumaric acid. (2) In alkaptonuria, one of the enzymes in this pathway, homogentisate 1, 2-dioxygenase (HGO), is al)sent, leading to the accunmlation of homogentisic acid (HGA). (2) HGA mad its metabolites accumulate in collagenous tissues causing ochronosis, characterized by darkened cartilaginous tissues, arthritis and joint destruction, and deterioration of cardiac valves. (3)

Ochronotic pigmentation of the laryngeal and tracheal cartilages has been described at autopsy in case reports. (4) We report the first case of" alkaptonuria diagnosed premortem by flexible bronchoscopy.

CASE REPORT

A 68-year-old white man was admitted to the hospital electively for cardiac valve replacement surgery. He had congestive heart failure due to severe aortic valve and mitral valve stenoses. His medical history was remarkable for multiple joint replacement surgeries since age 46 years for polyarticular erosive arthropathy presumed to be due to seronegative rheumatoid arthritis. On physical examination, there were no peripheral stigmata suggestive of ochronosis.

The patient underwent mitral valve and aortic valve replacements with St. Jude mechanical valves (St. Jude Medical Inc.; St. Paul, MN), and a tricuspid valve repair with a bilateral asymmetric Kay annuloplasty. On postoperative day 15, he was evaluated for failure to wean from mechanical ventilation due to post-pump ARDS and ventilator-associated pneumonia.

Bronchoscopy was performed prior to pereutaneous dilatational tracheotomy. This revealed circumferential strikingly dark-colored airways, most prominent in the trachea and mainstem bronchi, extending distally into all airways with overlying desiccated black secretions (Fig 1). Despite several attempts at cleaning the central airways with forceps extraction and copious saline solution irrigation, the mucosa remained hyperpigmented. Histologic examination of bronchial mucosal biopsy specimens and the desiccated secretions showed acute bronchitis and necrotic debris, respectively. Fontana-Masson staining disclosed that the pigmentation was negative tot melanin. Microbiological studies of bronchial secretions revealed no growth of pathogenic organisms.

[FIGURE 1 OMITTED]

Given the patient's history' of polyarticular erosive arthropathy, cardiac surgery for valvular stenoses, and the dark-colored airways, testing for plasma HGA was performed. The level was elevated at 12.6 [micro]g/mL, establishing the diagnosis of alkaptonuria. Despite initiating high-dose ascorbic acid treatment, the patient died from multisystem organ failure.

DISCUSSION

La Du and colleagues (2) were the first to describe the metabolic derangement responsible for the observed phenotype of ochronosis by demonstrating the deficiency of HGO activity in the liver of a patient with alkaptonuria. Elevation in urinary HGA excretion by a factor of 100 to 600 or the detection of HGA in plasma is considered diagnostic for alkaptonuria. (4) Our patient was anuric due to acute tubular necrosis. However, HGA was detected in plasma, thereby establishing the diagnosis of alkaptonuria. Prior to the development of gas chromatographic-mass spectrophotometric assays to measure urine and plasma HGA levels, (5) alkaptonuria was diagnosed based on the property of urine HGA to turn dark on prolonged exposure to room air or with the addition of sodium hydroxide. (1) On prolonged exposure of urine to room air or by alkalinizing urine, HGA in the urine oxidizes to benzoquinones, which in turn form melanin-like polymers, (5) and turns black within minutes.

Case reports of ochronotiv pigmentation of the laryyngeal and tracheal cartilages have been described at autopsy in patients with an established diagnosis of alkaptonuria, suggesting that HGA and its metabolites accumulate in these tissues. (4) In alkaptonuria, the deficiency of HGO causes excretion of large quantities of HGA daily in the urine and other bodily secretions such as cerumen and sweat. (4) As mentioned earlier, a milieu that facilitates the oxidation of HGA is necessary for the generation of benzoquinones and melanin-like polymers. (5) There are several opportunities for the generation of oxygen-free radicals in a patient receiving mechanical ventilation and high concentrations of oxygen. Healthy volunteers breathing pure oxygen develop hyperoxic tracheobronchitis mediated through the production of reactive oxygen species with erythema and edema of large airways observed bronchoscopically, and is thought to reflect oxygen toxicity on the tracheal and bronchial mucosa. (6) Hyperoxia also promotes the insudation of inflammatory cells, which are also sources of oxygen-derived free radicals. (6) Therefore, the oxidation of HGA and its metabolites by reactive oxygen species can lead to the diffusely dark-colored pigmentation of the cartilaginous tracheobronchial tree and its secretions.

This case is the first report of alkaptonuria diagnosed premortem using flexible bronchoscopy. The bronchoscopic finding of circumferential diffusely hyperpigmented airways should raise the suspicion of alkaptonuria and further investigation for this diagnosis can be performed by testing urine or plasma for HGA levels.

REFERENCES

(1) Garrod E. The Croonian lectures on inborn errors of metabolism: lecture II: Alkaptonuria. Lancet 1908; 2:73-79

(2) La Du BN, Zannoni VG, Laster L, et al. The nature of the defect in tyrosine metabolism in alkaptonuria. J Biol Chem 1958; 230:251-260

(3) Phornphutknl C, Introne wJ, Perry MB, et al. Natural history of alkaptonuria. N Engl J Med 2002; 347:2111-2121

(4) McClure J, Smith PS, Gramp AA. Calcium pyrophosphate dihydrate (CPPD) deposition in ochronotic arthropathy. J Clin Pathol 1983; 36:894-902

(5) Lustberg TJ, Schulman JD, Seegmiller JE. The preparation and identification of various adducts of oxidized homogentisic acid and the development of a new sensitive colorimetric assay for homogentisic acid. Clin Chim Acta 1971; 35:325-333

(6) Sackner MA, Landa J, Hirsch J, et al. Pulmonary effects of oxygen breathing: a 6-hour study in normal men. Ann Intern Med 1975; 82:40-43

* From the Division of Pulmonary and Critical Care Medicine (Drs. Parambil, Daniels, and Utz) and Department of Cardiovascular Surgery (Dr. Zehr), Mayo Clinic, Rochester, MN.

Manuscript received May 3, 2005; revision accepted May 28, 2005.

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal. org/misc/reprints.shtml).

Correspondes to: James P. Utz, MD, Division of Pulmonary and Critical Care Medicine, Dest East 18, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: utz.james@mayo.edu

COPYRIGHT 2005 American College of Chest Physicians
COPYRIGHT 2005 Gale Group

Return to Alkaptonuria
Home Contact Resources Exchange Links ebay